Clinical trials
Phase 1/2 Non-Muscle Invasive Bladder Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
34 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2012 | 2 |
| 2014 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 5 |
| 2019 | 2 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 9 |
| Active, not recruiting | 5 |
| Not yet recruiting | 5 |
| Terminated | 4 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ImmunityBio, Inc. | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| Aadi Bioscience, Inc. | 1 |
| Abnoba Gmbh | 1 |
| Altor BioScience | 1 |
| Asieris Pharmaceutical Technologies Co., Ltd. | 1 |
| Baylor College of Medicine | 1 |
| Binhui Biopharmaceutical Co., Ltd. | 1 |
| Ding-Wei Ye | 1 |
| Fudan University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-Muscle Invasive Bladder Neoplasms | 34 |
| Urinary Bladder Neoplasms | 17 |
| Carcinoma, Transitional Cell | 5 |
| Neoplasms | 4 |
| Urologic Neoplasms | 3 |
| Carcinoma in Situ | 2 |
| Urogenital Neoplasms | 2 |
| Lower Urinary Tract Symptoms | 1 |
| Neoplasm Metastasis | 1 |
| Photosensitivity Disorders | 1 |
Trials
Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.